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Optic neuritis (ON), an inflammatory demyelinating optic nerve disease, occurs in multiple sclerosis (MS).
Pathological mechanisms and potential treatments for ON have been studied via experimental autoimmune
MS models. However, evidence suggests that virus-induced inflammation is a likely etiology triggering MS and
ON; experimental virus-induced ON models are therefore required. We demonstrate that MHV-A59, a mouse
hepatitis virus (MHV) strain that causes brain and spinal cord inflammation and demyelination, induces ON by
promoting mixed inflammatory cell infiltration. In contrast, MHV-2, a nondemyelinating MHV strain, does not
induce ON. Results reveal a reproducible virus-induced ON model important for the evaluation of novel therapies.
Significant neuronal damage, with loss of retinal ganglion
cell (RGC) axons that comprise the optic nerve, occurs follow-
ing inflammatory optic neuritis (ON) and correlates with per-
manent vision loss (2, 6, 28). Experimental ON is a useful
model to examine mechanisms of neuronal damage in multiple
sclerosis (MS) because RGCs can readily be labeled and quan-
tified (23). Rodents immunized with myelin proteins develop
experimental autoimmune encephalomyelitis (EAE), a model
of MS with inflammation in the brain, spinal cord, and optic
nerves (12). Mechanisms of neuronal damage during ON in
EAE have been examined but vary between chronic (16, 19)
and relapsing (23) EAE models, suggesting that different
causes of ON may mediate vision-threatening neuronal dam-
age by distinct mechanisms.
MS may be caused by a viral infection triggering an immune
response against myelin (1, 26). Studies of virus-mediated
models of MS are therefore important for our understanding
of disease mechanisms and the development of novel thera-
pies. While virus-induced models of MS exist (15, 26), the
incidence of ON has not been characterized.
Mouse hepatitis virus (MHV) infection in mice has been
used as a model for virus-induced demyelination that mimics
many pathological features of MS (9, 13, 15, 27, 29). Some
neurotropic strains of MHV induce a biphasic neurological
disease with acute meningoencephalitis, followed by chronic
demyelination (15). Similarly to results for autoimmune mod-
els of MS, Dandekar et al. recently demonstrated that axonal
damage occurs in mice with MHV-induced demyelination (3).
It is not known whether the inflammatory demyelination and
axonal loss observed to occur in the MHV-infected mouse
brain and spinal cord also affect the optic nerve.
In the current study, we inoculated mice with plaque-puri-
fied demyelinating strain MHV-A59 (14, 15) and nondemyelin-
ating strain MHV-2 (10). MHV-A59 infects a variety of cell
types, including neurons, astrocytes, oligodendrocytes, micro-
glia, and ependymal cells (11, 13, 15, 30), in the central nervous
system (CNS) and causes acute encephalitis, meningitis, hep-
atitis, and chronic demyelination. In contrast, MHV-2, a strain
closely related to MHV-A59, has a limited ability to invade the
brain and spinal cord, causing meningitis without encephalitis
or demyelination (4, 20), making it an appropriate experimen-
tal negative control for our understanding of the mechanisms
of MHV-A59-induced CNS inflammatory disease processes.
MHV-A59 and MHV-2 were propagated and assayed as
described previously (20). Four-week-old, virus-free, C57BL/6
mice (Jackson Laboratory) were inoculated intracranially with
50% lethal doses of MHV-A59 (2,000 PFU) or MHV-2 (50
PFU), as described previously (20), and monitored daily for
mortality and signs of disease (15, 20). Mice were sacrificed 3,
5, 7, 15, or 30 days postinoculation and perfused with phos-
phate-buffered saline followed by phosphate-buffered saline
containing 4% paraformaldehyde. Liver, brain, spinal cord,
and optic nerve tissues were collected, postfixed in 4% para-
formaldehyde overnight at room temperature, and embedded
in paraffin. To confirm expected virulence, livers were cut in
5-m sections and stained with hematoxylin and eosin (H&E),
and pathology of moderate to severe hepatitis was character-
ized by multiple foci of necrosis (data not shown), similarly to
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methods from prior studies (17, 20). Experiments were re-
peated three times with three to five mice in each group.
To characterize virus-induced inflammation in the brain,
5-m coronal sections were stained with H&E. Both MHV-
A59 and MHV-2 induced meningitis (Fig. 1A and B), similarly
to findings from prior studies (20), although the type of inflam-
matory cells present was not fully characterized previously.
Serial sections were therefore stained for immunohistochemi-
cal analysis by the avidin-biotin-immunoperoxidase technique
(Vector Laboratories, Burlington, CA) using 3,3-diaminoben-
zidine as the substrate and a 1:100 dilution of anti-CD45 (leu-
kocyte common antigen [LCA] LY-5; BD Pharmingen), anti-
CD11b (OX42; Santa Cruz Biotechnology), or anti-CD3 (PC3/
188A; Santa Cruz) as the primary immunoglobulin G antibody.
LCA staining confirmed that the increased numbers of cells in
the meninges of the MHV-A59- or MHV-2-infected CNS con-
sist predominantly of infiltrating inflammatory cells (Fig. 1C
and D). Similarly to results from prior studies (20), MHV-A59
also induced focal acute encephalitis, characterized by inflam-
matory infiltrates in brain parenchyma with perivascular cuff-
ing (Fig. 1E and G), whereas in the MHV-2-infected brain,
inflammatory cells were restricted to the meninges, choroid
plexus, and subependymal region, with minimal, if any, inva-
sion of brain parenchyma (Fig. 1F and H). The majority of
infiltrating cells were CD11b, a macrophage/microglia
marker (Fig. 1I and J). Some CD3-stained infiltrating T cells
were also found (data not shown), although nonspecific back-
ground staining of neurons with available anti-CD3 antibodies
made staining difficult to quantify. Together, these data suggest
that MHV-induced CNS inflammation consists of mixed inflam-
matory cells, predominantly macrophages/microglia. Viral anti-
gen was stained (5), and the presence of MHV-A59 antigen in the
brain was confirmed, as in prior studies (data not shown).
Pathology was also assessed in five to seven cross-sections of
spinal cord from cervical, thoracic, and lumbar regions. Simi-
larly to results for the brain, H&E and LCA staining demon-
strated that both MHV-A59 and MHV-2 induced meningitis
(data not shown), whereas only MHV-A59 induced myelitis
(Fig. 2A and C). In MHV-2 infection, inflammatory cells were
rare and restricted to an area near the ependymal cell lining of
the central canal (Fig. 2B and D). Similarly to results for the
brain, the majority of inflammatory cells were CD11b (data
not shown). Luxol fast blue (LFB) staining (20) was performed
to visualize myelin. Demyelinating plaques developed as early
as day 5 postinoculation in MHV-A59-infected mice (Fig. 2E),
with no demyelination in MHV-2-infected mice (Fig. 2F). De-
myelinating plaques were quantified on a 0-to-3 scale in four
quadrants from two spinal cord levels for each mouse; thus,
approximately 100 total quadrants were examined for each
virus over three experiments. Day 30 postinoculation tissue
sections from MHV-A59-infected mice showed a pattern of
demyelination similar to that on day 5, but the number and
area of plaques were larger (Fig. 2G), and MHV-2-infected
mice did not exhibit any demyelination. To avoid a high mor-
tality rate of MHV-2 due to hepatitis, we used 50% lethal
doses (50 PFU). However, to ensure that the inability of
MHV-2 to cause encephalitis or demyelination is not dose
dependent, we also inoculated mice with MHV-A59 at 50
PFU. MHV-A59 produced larger demyelinating lesions when
given at 2,000 PFU than at 50 PFU, but with both doses, 100%
FIG. 1. Histopathology of brain sections during acute infection
with MHV-A59 compared to MHV-2. Serial coronal sections (5 m
thick) from MHV-A59- and MHV-2-infected mice at day 5 postin-
oculation were stained with H&E (A and B) or immunostained for
LCA (C to H) or CD11b (I and J). Histopathology shows acute
meningitis characterized by brisk leptomeningeal inflammatory in-
filtration in the subarachnoid space of the basal forebrain in both
MHV-A59-infected (A and C) and MHV-2-infected (B and D)
mice. Coronal sections stained for LCA show acute encephalitis in
the MHV-A59-infected mouse brain, characterized by the presence
of inflammatory infiltrates throughout the parenchyma (E) and the
formation of perivascular cuffing (G) at high magnification, whereas
in MHV-2 infection, infiltrating inflammatory cells were rarely ob-
served in brain parenchyma (F) and, when present, were restricted
to the subependyma (H). The majority of LCA-positive inflamma-
tory cells stained positive for the macrophage/microglia marker
CD11b in MHV-A59-infected brain parenchyma (I), and the few
positive cells in the MHV-2-infected brain (J) remained restricted
to the subependyma (arrows). Original magnifications are 100 for
panels A to D and H and 200 for panels G, I, and J. Panels E and
F are laser-scanned images.
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of mice were affected. Our results confirm earlier findings that
MHV-A59 induces demyelination whereas MHV-2 is non-
demyelinating at day 30 (20). Demyelination was not previ-
ously assessed at earlier time points. Here we demonstrate that
demyelination begins as early as day 5 postinoculation, indi-
cating that MHV-A59-induced myelin damage begins at the
time of acute inflammation, similarly to what is observed for
MS and EAE lesions (12).
The presence of LCA-positive inflammation and associated
demyelination in the brain and spinal cord led us to hypothe-
size that MHV-A59-infected mice may develop ON similar to
experimental ON in mice with EAE. Optic nerves from MHV-
A59- and MHV-2-infected mice were cut into 5-m longitudi-
nal sections and stained with H&E and inflammatory cell
markers. For comparison, relapsing EAE was induced in
8-week-old SJL/J mice by immunization with proteolipid pro-
tein peptide, as described previously (23). Mice were sacrificed
on day 11 postimmunization, when there were incidences of
ON peaks (23), and optic nerves were isolated. Inflammatory
cells infiltrating the optic nerve sheath and parenchyma are
shown by H&E and LCA staining (Fig. 3A and B) 5 days after
inoculation with MHV-A59, with results similar to inflamma-
FIG. 2. Comparative histopathology of MHV-A59- and MHV-2-infected mouse spinal cords. Serial cross sections (5 m thick) from MHV-
A59- and MHV-2-infected mouse spinal cords at day 5 postinoculation were stained with H&E (A and B), LCA (C and D), or LFB (E and F).
Several inflammatory lesions (A), with infiltrating LCA-positive cells (C), were observed in the MHV-A59-infected mouse spinal cord (arrows
indicate lesion area), whereas in the MHV-2-infected mouse spinal cord no parenchymal lesions were observed (B), with only rare LCA-positive
infiltrates observed near the central canal (D). An adjacent section of an MHV-A59-infected spinal cord shows a loss of myelin by LFB staining
(E) (arrow indicates demyelinated area), whereas normal myelin was observed in an MHV-2-infected mouse spinal cord (F). Original magnifi-
cation, 40. (G) Quantification of demyelinated plaques identified in day 5 and day 30 spinal cords. Four quadrants were scored at two separate
levels in each spinal cord, and the percentages of mice and percentages of quadrants observed to contain demyelinated plaques are shown. Cumulative
data representing three experiments, with three to five mice/group in each experiment, are shown. Mean (standard error of the mean) severity of
demyelination is scored on a four-point scale (0, none; 1, rare foci; 2, a few areas of demyelination; 3, large [confluent] areas of demyelination).
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tion seen for EAE ON (Fig. 3C and D). In contrast, optic
nerves from MHV-2-infected mice did not develop ON (Fig.
3E and F) and had a histological appearance similar to that of
control optic nerves (Fig. 3G). Both CD11b and fewer CD3
cells were noted in MHV-A59-infected optic nerves, similarly
to results for the brain; however, background staining levels for
these and control nerves made the results difficult to interpret
(data not shown), and as better antibodies become available,
further evaluation will be needed to confirm these observa-
tions. By day 15 after MHV-A59 infection, optic nerve inflam-
mation completely resolved (Fig. 3H).
Detection of viral antigen in optic nerves was limited to
axons, because there are no neuronal cell bodies present. Light
diffuse staining detected in optic nerves from MHV-A59-in-
fected mice (Fig. 3I) but not MHV-2-infected mice (Fig. 3J)
suggests that the MHV-A59 viral antigen is likely present in
optic nerve axons. Consistent with the observed pattern of
inflammation, optic nerves from MHV-A59-infected mice had
areas of demyelination detected by LFB staining 30 days posti-
noculation (Fig. 3K), whereas no demyelination occurred in
MHV-2-infected mice (Fig. 3L).
The degree of optic nerve inflammation was scored on a
FIG. 3. Optic nerve histopathology from MHV-A59-infected mice, MHV-2-infected mice, and mice with EAE. Longitudinal sections (5 m
thick) of optic nerves from MHV-infected mice and mice with EAE are shown. Numerous inflammatory cells are evident in an MHV-A59-infected
optic nerve with ON 5 days (d5) postinoculation stained by H&E (A) and LCA (B). Similar inflammation is seen in the EAE optic nerve 11 days
postimmunization (C and D). The optic nerve 5 days after inoculation with MHV-2 (E) shows a lack of inflammation, with no LCA staining
detected (F), similar to the histology of a normal, control optic nerve (G). MHV-A59-induced inflammation resolves by day 15 postinoculation (H).
Viral antigen staining of an optic nerve from an MHV-A59-infected mouse shows low-level axonal staining (I), whereas no viral antigen is detected
in an MHV-2-infected mouse optic nerve (J). LFB staining 30 days postinoculation demonstrates a loss of myelin in a mouse with MHV-A59 ON
(K) and normal myelin staining in an MHV-2-infected mouse (L). Original magnification, 20.
FIG. 4. Incidence of ON and axonal loss in MHV-infected mice and mice with EAE. (A) ON, determined by the presence of any level of
inflammation in the optic nerve, is detected as early as day 3 after inoculation with MHV-A59. The incidence increases by day 5, persists at day
7, and resolves by day 15. In contrast, almost no MHV-2-infected mice develop ON over the same time course. The mean (standard error of the
mean) incidence from three experiments is shown. (B) The peak incidence of MHV-A59-induced ON, detected at day 5 postinoculation, is 48%
(10 of 21 nerves), whereas only 1 of 21 nerves from MHV-2-infected mice developed ON. Sixty percent (6 of 10) of optic nerves from mice with
EAE developed ON at the peak of inflammation on day 11 postimmunization. (C) The area of axonal staining (mean standard error of the mean)
detected by Bielschowsky silver impregnation is significantly lower in optic nerves from MHV-A59-infected mice than in optic nerves from control,
uninfected mice or MHV-2-infected mice (*, P  0.05).
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0-point (no inflammation) to 4-point (severe inflammation)
scale described previously (22–24), with any amount of inflam-
mation (score of 1 to 4) considered positive for ON. ON was
detected as early as 3 days after inoculation with MHV-A59,
with the peak incidence at day 5 and resolution by day 15 (Fig.
4A). At the peak of ON (day 5), almost 50% (10 of 21) of optic
nerves examined from MHV-A59-infected mice had ON (Fig.
4B), with an average relative inflammation score of 1.7  0.21,
whereas only 1 of 21 nerves from MHV-2-infected mice had
even mild inflammation (score of 1.0). The incidence of ON in
mice with EAE was 60% (6 of 10), with a 1.83  0.31 average
inflammation score, similar to results from prior studies (23,
24) and comparable to the incidence induced by MHV-A59
infection. To examine whether MHV-A59-induced ON also
leads to axonal loss, optic nerves were stained by Bielschowsky
silver impregnation, and the area of axonal staining was quan-
tified as described previously (25). Thirty days postinoculation,
nerves from MHV-A59-infected mice showed significantly de-
creased axonal staining compared to control nerves or nerves
from MHV-2-infected mice (Fig. 4C).
Our results demonstrate that MHV-A59, but not MHV-2,
induces demyelination in the CNS during acute encephalitis as
early as 5 days postinoculation, in addition to the chronic
demyelination previously observed to occur at day 30 (20). We
demonstrated that inflammation triggered by MHV infection
consists of mixed inflammatory cells, predominantly macro-
phages/microglia, which differs somewhat from autoimmune
models of MS, where infiltrating T cells are significant contrib-
utors to pathology (12, 18). Importantly, MHV-A59 also in-
duces ON with similar levels of severity and incidence, as seen
in the autoimmune antigen-triggered EAE model. Experimen-
tal ON is an important model being used to characterize neu-
ronal damage and develop novel therapies for MS (7, 19, 21,
24), but studies have shown that different EAE models, in-
duced by distinct antigens, lead to different mechanisms of
RGC loss (8, 23). The MHV-A59-induced ON model will
provide a critical adjunct to study the pathophysiology of ON
secondary to virus-mediated inflammation, as this is one mech-
anism that can cause ON and MS in human patients.
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